Behbahani Ali

CIK 000161386711 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001613867

Recent Transactions

36 trades

Purchase
Marker Therapeutics, Inc.$MRKR
Common Stock
2024-12-23$3.20/sh+554,250→ 1,625,678 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-12-13$2.50/sh+5,750→ 63,334 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+61,865→ 185,594 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+185,595→ 556,782 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+61,865→ 185,594 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-09-20$4.78/sh+3,007→ 57,584 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+500,000→ 3,614,486 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+1,023,103→ 1,023,103 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+2,091,383→ 3,114,486 total
Conversion
MBX Biosciences, Inc.$MBX
Series A Convertible Preferred Stock
2024-09-16−12,299,854→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Convertible Preferred Stock
2024-09-16−25,142,840→ 0 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2024-07-01+1,144,686→ 1,144,686 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-06-21$4.98/sh+2,887→ 54,577 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2024-06-13+22,500→ 22,500 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-12+22,100→ 22,100 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2024-06-11+5,190→ 5,190 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2024-06-06+30,550→ 30,550 total
Award
CVRx, Inc.$CVRX
Stock Option (right to buy)
2024-06-04+27,250→ 27,250 total
Award
CVRx, Inc.$CVRX
Stock Option (right to buy)
2024-06-04+20,961→ 20,961 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to buy)
2024-05-30+13,000→ 13,000 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2024-05-28+8,011→ 8,011 total
Award
Korro Bio, Inc.$KRRO
Common Stock
2024-04-22$56.00/sh+17,857→ 1,090,793 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-04-08+371,187→ 371,187 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-04-08+123,729→ 123,729 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-04-08+123,729→ 123,729 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-03-15$4.54/sh+3,166→ 51,690 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2024-01-15+40,950→ 40,950 total
Exercise/Conversion
CVRx, Inc.$CVRX
Common Stock
2023-12-14$0.24/sh+316→ 316 total
Exercise/Conversion
CVRx, Inc.$CVRX
Stock Option (right to buy)
2023-12-14−316→ 0 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2023-09-15+552,263→ 1,380,658 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2023-09-15$3.60/sh+3,299→ 44,069 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2023-07-03+933,317→ 933,317 total
Other
Arcellx, Inc.$ACLX
Common Stock
2023-06-01+113→ 339 total
Other
Arcellx, Inc.$ACLX
Common Stock
2023-06-01+28→ 85 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2023-03-16$1.67/sh+7,111→ 35,115 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total

Behbahani Ali

Recent Transactions

Companies

Recent Filings

Address